Mechanical Power and Mortality in Mechanically Ventilated Adults

September 18, 2026 updated by: Zagazig University

Relation Between Mechanical Power and Mortality in Mechanically Ventilated Adult Patients

This prospective observational cohort study aims to investigate the relationship between mechanical power during the first 72 hours of invasive mechanical ventilation and 28-day mortality in mechanically ventilated adult patients admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This prospective observational cohort study will enroll adult patients admitted to the Surgical Intensive Care Unit who require invasive mechanical ventilation. Mechanical power will be calculated during the first 72 hours of invasive mechanical ventilation using ventilatory parameters recorded during routine clinical care. Patient demographic and clinical characteristics, respiratory and ventilatory parameters, and relevant laboratory data will be recorded. Patients will be followed during their ICU stay, and 28-day mortality will be assessed as the primary outcome. The association between mechanical power and 28-day mortality will be evaluated using appropriate statistical analyses, including receiver operating characteristic (ROC) curve analysis to assess the predictive performance of mechanical power.

Study Type

Observational

Enrollment (Estimated)

116

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sharqia Province
      • Zagazig, Sharqia Province, Egypt
        • Surgical Intensive Care Unit, Zagazig University Hospitals
        • Contact:
          • Zagazig University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients requiring invasive mechanical ventilation and admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

Description

Inclusion Criteria:

  • Age ≥18 years.
  • Both sexes.
  • Patients requiring invasive controlled mechanical ventilation in the ICU and expected to require mechanical ventilation for at least 72 hours.
  • Enrollment within the first 8 hours after initiation of invasive mechanical ventilation.
  • Acceptance and written informed consent from a first-degree relative.

Exclusion Criteria:

  • Predominant spontaneous breathing or weaning modes during the first 48 hours.
  • Severe hemodynamic instability precluding standardized measurements.
  • Prolonged mechanical ventilation prior to ICU admission.
  • Pregnancy.
  • Chest trauma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Mechanically Ventilated Adult Patients

Adult patients requiring invasive mechanical ventilation and admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
28-Day Mortality
Time Frame: At 28 days after initiation of invasive mechanical ventilation

All-cause mortality within 28 days after initiation of invasive mechanical ventilation.

At 28 days after initiation of invasive mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Driving Pressure and Plateau Pressure
Time Frame: At 24, 48, and 72 hours after initiation of invasive mechanical ventilation

Correlation between mechanical power and driving pressure and plateau pressure at 24, 48, and 72 hours.

At 24, 48, and 72 hours after initiation of invasive mechanical ventilation
Ventilator-Free Days
Time Frame: Through 28 days after initiation of invasive mechanical ventilation

Number of ventilator-free days within the first 28 days.

Through 28 days after initiation of invasive mechanical ventilation
ICU Length of Stay
Time Frame: From ICU admission until ICU discharge or death, through 28 days after initiation of invasive mechanical ventilation

Duration of stay in the intensive care unit

From ICU admission until ICU discharge or death, through 28 days after initiation of invasive mechanical ventilation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Ghada M Abd Elrazik, Prof of anesthesia and Icu, Zagazig University
  • Study Chair: Asmaa M Galal Eldin, Assistant prof anesthesia,Icu, Zagazig University
  • Study Chair: Ahmed A Ibrahim, Lecturer of anesthesia, Icu, Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 10, 2026

Primary Completion (Estimated)

May 25, 2027

Study Completion (Estimated)

August 18, 2027

Study Registration Dates

First Submitted

September 9, 2026

First Submitted That Met QC Criteria

September 18, 2026

First Posted (Actual)

September 23, 2026

Study Record Updates

Last Update Posted (Actual)

September 23, 2026

Last Update Submitted That Met QC Criteria

September 18, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ZU-MP-MORTALITY-2026

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.